DHT

DHT (DHT) is a company in Vietnam's Health Care sector, listed on HNX. The stock last traded at 56,600 VND, little changed on the session, giving a market capitalization of 5.8 trillion VND.

On valuation, DHT trades at a price-to-earnings ratio of 131.2 and a price-to-book of 5.2. That is a premium to the Health Care sector average P/E of 18.9. Return on equity of 3.9% points to weak profitability relative to the company's equity base, below the sector average of 11.5%. Trailing earnings per share stand at 487 VND.

Aveluro tracks 6 news items mentioning DHT, where recent coverage skews negative (33% of articles). The most recent catalyst was a foreign flow event — "Foreign Investors Net Buy HPG, VIC, VPB as VN-Index Rises 20 Points". Aveluro's composite model rates DHT 8.7/10 (Very Bullish), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Recent developments around DHT include 5 notable classified events. On Aug 24, 2026, a market event was reported: HPG led foreign net buying on HOSE with over VND 106B in a session where the VN-Index gained 20 points to 1,788. On Jun 02, 2026, a market event was reported: Foreign investors net sold VND 562 billion on June 2, 2026, extending a recent selling trend. On May 27, 2026, a market event was reported: Foreign investors net sold nearly VND 800 billion (USD 31.4 million) on May 27, with VHM (VND 220B), HPG (VND 141B), VIC (VND 102B), FPT (VND 83B), and BSR (VND 51B) bearing the heaviest selling. On May 13, 2026, a market event was reported: Vietnam's top three pharma companies by market cap—DHG, IMP, and DHT—are now under foreign control or significant influence, with Taisho, Livzon, and ASKA as key shareholders. A recent a market event was reported: IMP is now majority-owned by China's Livzon after a VND 6,000B deal for 67.87% of shares.

The overall tone of recent coverage is negative, with 2 of 5 events carrying bearish sentiment.